|
ÁÖ½Äȸ»ç ¿À»óÇコÄɾî |
QA ºÐ¾ß °æ·ÂÁ÷ ä¿ë
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
ÀÓ»ó BD/RA/QA |
4³â¡è |
ä¿ë½Ã |
09.13 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Principal Regulatory Affairs Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
(ÁÖ)¿¥¾ÆÀÌÅØ |
ÀÇ·á±â±â QA °æ·ÂÁ÷ ä¿ë(ÄÚ½º´Ú »óÀå»ç)
°æ±â ÆòÅýà | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
|
|
|
(ÁÖ)¶óÀÌÆ®ÆÊÅØ |
Á¦¾àȸ»ç °³¹ßÆÀ RA ä¿ë °ø°í
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.28 |
|
|
Çѱ¹¾ËÄÜ |
[ALCON] Regulatory Affairs (RA) Specialist – °æ·Â
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
09.27 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] BD Associateä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
04.02 |
|
|
(ÁÖ)ÇÏÀ̼¾½º¹ÙÀÌ¿À |
ÀÓ»ó½ÃÇè °ü¸®ÀÚ(CRA) °æ·ÂÁ÷ ä¿ë
°æ±â °úõ½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
06.11 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
BDºÎ¼ BD Associate ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.22 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] Business Development Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
03.17 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] BD Assistant ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.27 |
|
|
(ÁÖ)Å¥¶óƼ½º |
ÀÓ»ó°³¹ßÆÀ ÀÓ»óQA Á¤±ÔÁ÷ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.13 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) ä¿ë_»ýµ¿BD °æ·ÂÀÚ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
08.03 |
|
|
(ÁÖ)Ç층½º |
[Ç층½º] Medical Writer ä¿ë
¼¿ï °³²±¸ | Çз¹«°ü |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.22 |
|
|
Çѱ¹½ºÆ®¶óÀÌÄ¿(ÁÖ) |
Business Development Manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
5³â¡è |
ä¿ë½Ã |
01.12 |
|
|
¿¡À̽º¸ÞµðÄ®(ÁÖ) |
Ç°Áú°ü¸®ºÎ RAºÎ¹® ½ÅÀÔ/°æ·Â ä¿ë
¼¿ï °µ¿±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.13 |
|